Local Institution

Ōsaka-sayama, Osaka 5898511

0 studies enrolling now · 3 studies all time

What they study most

Hepato Cellular Carcinoma (HCC), Hepatocellular Carcinoma, Liver Cancer

Studies at this site

• A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation — Running, not enrolling
• Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC — Completed
• First Line Hepato Cellular Carcinoma (HCC) — Completed